e-learning
resources
London 2016
Sunday, 04.09.2016
Drugs, bugs, BMI, and other problems in paediatric asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Duration of inhaled corticosteroid therapy in children with asthma and frequency of community-acquired pneumonia in them
Zoia Nesterenko (Lugansk, Ukraine), Zoia Nesterenko
Source:
International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Session:
Drugs, bugs, BMI, and other problems in paediatric asthma
Session type:
Thematic Poster
Number:
1250
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Zoia Nesterenko (Lugansk, Ukraine), Zoia Nesterenko. Duration of inhaled corticosteroid therapy in children with asthma and frequency of community-acquired pneumonia in them. Eur Respir J 2016; 48: Suppl. 60, 1250
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Community acquired pneumonia in asthma patients
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Asthma diagnosis in children with community-acquired pneumonia: New challenges
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Finding asthmatics suitable for omalizumab therapy in a district hospital
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Prevalence of refractory asthma in population with severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
The effect of treatment duration by inhaled glucocorticosteroids, on “cough variant asthma” in children
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Out-patient combination therapy with inhaled corticosteroids and bronchodilators is associated with lower in-hospital mortality in pneumonia in patient with COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
LATE-BREAKING ABSTRACT: Is treatment with inhaled corticosteroids in asthma associated with hospitalisations because of pneumonia?
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
FeNO-guided management of asthma during pregnancy reduces respiratory symptoms and asthma diagnosis in childhood
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016
Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Prolonged bronchodilator responsiveness after preschool virus-induced wheezing episodes may predict asthma persistence
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015
Pneumonia risk in COPD patients on long term inhaled corticosteroids – Data from the European COPD audit<%
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Patients with allergic and eosinophilic asthma in the German severe asthma registry
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Comparison of clinical features of severe persistent asthma and refractory asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Sesonal variations of severe asthma exacerbations in the US
Source: International Congress 2014 – Risk factors for respiratory disease
Year: 2014
Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia
Source: Eur Respir J 2011; 37: 36-41
Year: 2011
Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Predictors of exacerbations in asthma
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
COPD and pneumonia
Source: International Congress 2015 – Different data in COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept